Promising brain cancer drug combo study pulled before it started
Disease control
Terminated
This study aimed to test the safety of giving a combination of drugs (nivolumab plus either methotrexate or 5-azacytidine) directly into the fluid-filled spaces of the brain for people with recurrent brain tumors like medulloblastoma and ependymoma. The goal was to see if this di…
Phase: PHASE1 • Sponsor: Jeffrey Treiber • Aim: Disease control
Last updated May 15, 2026 11:53 UTC